SIMULECT
SIMULECT
Approved
DIN Number
02242815
Drug Class
Human
Market Date
Oct 23, 2000
Company
HC
novartis pharmaceuticals canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02242815
AIG Number0141982001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L04AC02 BASILIXIMAB
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification90:28.16.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
BASILIXIMABActive
Strength: 20 MG / VIAL
Monograph: BASILIXIMAB